Moving Beyond Smoking
Our industry stands at a pivotal moment. There is considerable interest among more than 30 million U.S. adult smokers in less harmful tobacco products. In response, we are leveraging the resources of our companies and making strategic investments to provide a diverse portfolio of products that satisfy adult preferences and facilitate the transition of adult smokers to smoke-free alternatives.
Our team of more than 250 scientists, physicians, product developers, engineers, and regulatory experts, shares a unified objective - to advance tobacco harm reduction. To achieve this, we allocate resources to scientific research that demonstrates the reduced harm potential of smoke-free tobacco products compared to cigarettes. Additionally, we support the product applications that we submit to the U.S. Food and Drug Administration (FDA).
Collaboratively, we are committed to exploring innovative products, seeking regulatory authorization from the FDA, and engaging constructively with regulatory bodies, the wider scientific community, and other stakeholders. Much of this important work takes place at our Center for Research & Technology located in Richmond, Virginia.
